Status:
RECRUITING
In-depth Analysis of the Immune Responses in the Upper Respiratory Tract of Influenza-infected Children
Lead Sponsor:
University Hospital, Geneva
Conditions:
Influenza Infection
Eligibility:
All Genders
2-5 years
Brief Summary
The NoseFlu-Kids project aims at characterizing the immune response in the upper respiratory tract in children aged 2 to 5 with a laboratory-confirmed influenza infection. The immune response during t...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Aged 2-5 years
- Presenting clinical signs of an influenza-like illness
- Having a concomitant positive laboratory test for influenza.
- Exclusion criteria:
- Immunosuppression
- Intubation or under invasive mechanical ventilation
- Co-infection with RSV or SARS-CoV-2
Exclusion
Key Trial Info
Start Date :
March 4 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06998264
Start Date
March 4 2025
End Date
November 1 2026
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geneva University Hospitals
Geneva, Switzerland, 1205